This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.
Aprecia’s Spritam is now available as a prescription drug. The first ever drug manufactured using 3D printing technology is now available to US patients with epilepsy. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year,
Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. ... This is the first in a line of central nervous system products Aprecia plans to introduce
The drug Spritam (levetiracetam), from Aprecia Pharmaceuticals, has been given the green light from the US regulator as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and ... experience. "This is the first in a line
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...